Advertisement
Advertisement

ACXP

ACXP logo

Acurx Pharmaceuticals, Inc. Common Stock

1.47
USD
Sponsored
+0.05
+3.52%
Jun 24, 15:58 UTC -4
Closed
exchange

After-Market

1.48

+0.01
+0.34%

Acurx Pharmaceuticals, Inc. Common Stock Profile

About

Acurx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. It focused on developing new antibiotics to treat infections. Acurx Pharmaceuticals Inc. is based in STATEN ISLAND, N.Y.

Info & Links

CEO

David P. Luci

Headquarters

259 LIBERTY AVENUE
STATEN ISLAND, NY 10305, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.acurxpharma.com

Auditor

CohnReznick LLP

Share holders

370

Employees

4

Acurx Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

6.34M

Enterprise Value

-2.92M

Enterprise Value/EBITDA(ttm)

0.38

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.30

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-215.54%

Return on Invested Capital(ttm)

-240.72%

Return on Assets(ttm)

-128.70%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-7.63M

Net Income Available to Common(ttm)

-7.50M

Diluted EPS(ttm)

-5.63

Share Statistics

Beta (5Y Monthly)

-1.92

52-Week Change

-87.80%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

4.30M

Dividend Yield

0.00%

Float4

2.27M

% Held by Insiders

20.30%

% Held by Institutions

11.53%

Balance Sheet

Total Cash(mrq)

9.25M

Total Cash Per Share(mrq)

2.15

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.18%

Quick Ratio(mrq)

3.18%

Book Value Per Share(mrq)

2.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-4.53

Free Cash Flow(ytd)

-6.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement